Budget Amount *help |
¥17,160,000 (Direct Cost: ¥13,200,000、Indirect Cost: ¥3,960,000)
Fiscal Year 2015: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2013: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
|
Outline of Final Research Achievements |
Here, we show that DCIR2 is a regulatory receptor for the activation of CD4+cDCs that impairs inflammation and T-cell immunity. Dcir2-/-CD4+cDCs show enhanced cytokine production and T-cell priming following TLR-mediated activation. Furthermore, Dcir2-/- mice exhibit TLR-mediated hyperinflammation. Upon antigenic immunization,Dcir2-/- mice show not only augmented T-cell responses but also progressive autoimmune pathogenesis. Thus, our findings highlight roles of Clec4A4 in regulation of the function of CD4+cDCs for control of the magnitude and quality of immune response.
|